The Liver Meeting 2021-Optimal HCV Treatment Approaches to Achieve Elimination

Video Transcription

Video Summary

The video panel of medical experts discusses optimal approaches for treating and eliminating hepatitis C, emphasizing simplified testing and treatment strategies using direct-acting antivirals (DAAs). Dr. Solomon discusses simplified approaches, Dr. Truskin focuses on treating individuals who inject drugs, and Dr. Wiles addresses curing HCV after DAA non-response. The panel stresses the need for simplification in HCV care to improve access. Additionally, they highlight the effectiveness of DAAs in individuals who use drugs, the importance of harm reduction programs, and the significance of treating acute and chronic infections. The panel also discusses resistance profiles, tailoring retreatment strategies, and the challenges of managing recurrent HCV infection. They emphasize simplifying treatment approaches and minimizing unnecessary monitoring. The speakers advocate for upfront treatment courses, reconsidering genotyping needs, and post-treatment confirmation. The panel addresses virologic relapse, reinfection, and the role of resistance testing in treatment decisions. Their goal is to simplify treatment protocols, improve access to care, and work towards global elimination of Hepatitis C.

Keywords

hepatitis C

medical experts

direct-acting antivirals

simplified testing

treatment strategies

individuals who inject drugs

HCV care

harm reduction programs

resistance profiles

retreatment strategies

reinfection

global elimination